These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12560338)

  • 1. Glucosylceramide, a neutral glycosphingolipid anticoagulant cofactor, enhances the interaction of human- and bovine-activated protein C with negatively charged phospholipid vesicles.
    Yegneswaran S; Deguchi H; Griffin JH
    J Biol Chem; 2003 Apr; 278(17):14614-21. PubMed ID: 12560338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral glycosphingolipid-dependent inactivation of coagulation factor Va by activated protein C and protein S.
    Deguchi H; Fernández JA; Griffin JH
    J Biol Chem; 2002 Mar; 277(11):8861-5. PubMed ID: 11741960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein S alters the active site location of activated protein C above the membrane surface. A fluorescence resonance energy transfer study of topography.
    Yegneswaran S; Wood GM; Esmon CT; Johnson AE
    J Biol Chem; 1997 Oct; 272(40):25013-21. PubMed ID: 9312108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thrombin-sensitive region of protein S mediates phospholipid-dependent interaction with factor Xa.
    Yegneswaran S; Hackeng TM; Dawson PE; Griffin JH
    J Biol Chem; 2008 Nov; 283(48):33046-52. PubMed ID: 18784085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The active site of membrane-bound meizothrombin. A fluorescence determination of its distance from the phospholipid surface and its conformational sensitivity to calcium and factor Va.
    Armstrong SA; Husten EJ; Esmon CT; Johnson AE
    J Biol Chem; 1990 Apr; 265(11):6210-8. PubMed ID: 2180944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A domain of membrane-bound blood coagulation factor Va is located far from the phospholipid surface. A fluorescence energy transfer measurement.
    Isaacs BS; Husten EJ; Esmon CT; Johnson AE
    Biochemistry; 1986 Aug; 25(17):4958-69. PubMed ID: 3768326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding energy of human coagulation protein C to acidic phospholipid vesicles contains a major contribution from leucine 5 in the gamma-carboxyglutamic acid domain.
    Zhang L; Castellino FJ
    J Biol Chem; 1994 Feb; 269(5):3590-5. PubMed ID: 8106403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties and active-site topographies of factor X Gla- and prothrombin Gla-domain chimeras of activated protein C.
    Qureshi SH; Yang L; Manithody C; Bae JS; Rezaie AR
    Biochim Biophys Acta; 2008 Sep; 1780(9):1080-6. PubMed ID: 18539155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of activated protein C to factors V and Va.
    Krishnaswamy S; Williams EB; Mann KG
    J Biol Chem; 1986 Jul; 261(21):9684-93. PubMed ID: 3755431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The active site of the thrombin-thrombomodulin complex. A fluorescence energy transfer measurement of its distance above the membrane surface.
    Lu RL; Esmon NL; Esmon CT; Johnson AE
    J Biol Chem; 1989 Aug; 264(22):12956-62. PubMed ID: 2546942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol enhances phospholipid-dependent activated protein C anticoagulant activity.
    Pecheniuk NM; Deguchi H; Griffin JH
    J Thromb Haemost; 2005 Feb; 3(2):340-5. PubMed ID: 15670041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.
    Deguchi H; Fernández JA; Pabinger I; Heit JA; Griffin JH
    Blood; 2001 Apr; 97(7):1907-14. PubMed ID: 11264150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.
    Mutucumarana VP; Duffy EJ; Lollar P; Johnson AE
    J Biol Chem; 1992 Aug; 267(24):17012-21. PubMed ID: 1512240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function.
    He X; Shen L; Villoutreix BO; Dahlbäck B
    J Biol Chem; 1998 Oct; 273(42):27449-58. PubMed ID: 9765274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity.
    Smirnov MD; Safa O; Regan L; Mather T; Stearns-Kurosawa DJ; Kurosawa S; Rezaie AR; Esmon NL; Esmon CT
    J Biol Chem; 1998 Apr; 273(15):9031-40. PubMed ID: 9535891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity.
    Seré KM; Janssen MP; Willems GM; Tans G; Rosing J; Hackeng TM
    Biochemistry; 2001 Jul; 40(30):8852-60. PubMed ID: 11467946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gamma-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding.
    Saller F; Villoutreix BO; Amelot A; Kaabache T; Le Bonniec BF; Aiach M; Gandrille S; Borgel D
    Blood; 2005 Jan; 105(1):122-30. PubMed ID: 15308562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
    Deguchi H; Bouma BN; Middeldorp S; Lee YM; Griffin JH
    J Thromb Haemost; 2005 May; 3(5):935-8. PubMed ID: 15869587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S.
    Hackeng TM; Yegneswaran S; Johnson AE; Griffin JH
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):757-64. PubMed ID: 10903136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.